{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:09:20Z","timestamp":1791025760403,"version":"4.1.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1093\/brain\/awl013","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T01:13:11Z","timestamp":1137460391000},"page":"676-685","source":"Crossref","is-referenced-by-count":92,"title":["Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations"],"prefix":"10.1093","volume":"129","author":[{"given":"Andrew F.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Joiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D. F.","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,1,16]]},"reference":[{"key":"key\n\t\t\t\t20171011191107_B1","doi-asserted-by":"crossref","unstructured":"Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J2002; 21: 6358\u201366.","DOI":"10.1093\/emboj\/cdf653"},{"key":"key\n\t\t\t\t20171011191107_B2","doi-asserted-by":"crossref","unstructured":"Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol1994; 68: 7859\u201368.","DOI":"10.1128\/JVI.68.12.7859-7868.1994"},{"key":"key\n\t\t\t\t20171011191107_B3","unstructured":"Budka H, Hainfellner JA, Almer G, Br\u00fccke T, Windl O, Kretzschmar HA, et al. A new Austrian family with fatal familial insomnia: brain pathology without detectable PrPres. Brain Pathol1997; 7: 1267."},{"key":"key\n\t\t\t\t20171011191107_B4","doi-asserted-by":"crossref","unstructured":"Cardone F, Liu QG, Petraroli R, Ladogana A, D'Alessandro M, Arpino C, et al. Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients. Brain Res Bull1999; 49: 429\u201333.","DOI":"10.1016\/S0361-9230(99)00077-5"},{"key":"key\n\t\t\t\t20171011191107_B5","doi-asserted-by":"crossref","unstructured":"Chen SG, Parchi P, Brown P, Capellari S, Zou W, Cochran EJ, et al. Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med1997; 3: 1009\u201315.","DOI":"10.1038\/nm0997-1009"},{"key":"key\n\t\t\t\t20171011191107_B6","unstructured":"Collinge J. Human prion diseases: aetiology and clinical features. In: Growdon JH, Rossor M, editors. The dementias. Newton, MA: Butterworth-Heinemann; 1998. p. 113\u201348."},{"key":"key\n\t\t\t\t20171011191107_B7","doi-asserted-by":"crossref","unstructured":"Collinge J. Variant Creutzfeldt-Jakob disease. Lancet1999; 354: 317\u201323.","DOI":"10.1016\/S0140-6736(99)05128-4"},{"key":"key\n\t\t\t\t20171011191107_B8","doi-asserted-by":"crossref","unstructured":"Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci2001; 24: 519\u201350.","DOI":"10.1146\/annurev.neuro.24.1.519"},{"key":"key\n\t\t\t\t20171011191107_B9","unstructured":"Collinge J, Palmer MS. Prion diseases. Oxford: Oxford University Press; 1997."},{"key":"key\n\t\t\t\t20171011191107_B10","doi-asserted-by":"crossref","unstructured":"Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet1991; 337: 1441\u20132.","DOI":"10.1016\/0140-6736(91)93128-V"},{"key":"key\n\t\t\t\t20171011191107_B11","doi-asserted-by":"crossref","unstructured":"Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, et al. Inherited prion disease with 144 base pair gene insertion: 2. Clinical and pathological features. Brain1992; 115: 687\u2013710.","DOI":"10.1093\/brain\/115.3.687"},{"key":"key\n\t\t\t\t20171011191107_B12","doi-asserted-by":"crossref","unstructured":"Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD. Nature1996; 383: 685\u201390.","DOI":"10.1038\/383685a0"},{"key":"key\n\t\t\t\t20171011191107_B13","doi-asserted-by":"crossref","unstructured":"Frosh A, Smith LC, Jackson CJ, Linehan JM, Brandner S, Wadsworth JD, et al. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet2004; 364: 1260\u20132.","DOI":"10.1016\/S0140-6736(04)17143-2"},{"key":"key\n\t\t\t\t20171011191107_B14","doi-asserted-by":"crossref","unstructured":"Furukawa H, Doh-ura K, Kikuchi H, Tateishi J, Iwaki T. A comparative study of abnormal prion protein isoforms between Gerstmann-Str\u00e4ussler-Scheinker syndrome and Creutzfeldt-Jakob disease. J Neurol Sci1998; 158: 71\u20135.","DOI":"10.1016\/S0022-510X(98)00096-3"},{"key":"key\n\t\t\t\t20171011191107_B15","doi-asserted-by":"crossref","unstructured":"Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB. Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med1996; 2: 59\u201364.","DOI":"10.1038\/nm0196-59"},{"key":"key\n\t\t\t\t20171011191107_B16","doi-asserted-by":"crossref","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull2003; 66: 213\u201339.","DOI":"10.1093\/bmb\/66.1.213"},{"key":"key\n\t\t\t\t20171011191107_B17","doi-asserted-by":"crossref","unstructured":"Hainfellner JA, Brantner-Inthaler S, Cerven\u00e1kov\u00e1 L, Brown P, Kitamoto T, Tateishi J, et al. The original Gerstmann-Straussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol1995; 5: 201\u201311.","DOI":"10.1111\/j.1750-3639.1995.tb00596.x"},{"key":"key\n\t\t\t\t20171011191107_B18","doi-asserted-by":"crossref","unstructured":"Harder A, Gregor A, Wirth T, Kreuz F, Schulz-Schaeffer WJ, Windl O, et al. Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J Neurol2004; 251: 715\u201324.","DOI":"10.1007\/s00415-004-0409-0"},{"key":"key\n\t\t\t\t20171011191107_B19","doi-asserted-by":"crossref","unstructured":"Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, et al. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991\u20132002. Ann Neurol2004; 55: 851\u20139.","DOI":"10.1002\/ana.20127"},{"key":"key\n\t\t\t\t20171011191107_B20","doi-asserted-by":"crossref","unstructured":"Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science1998; 279: 827\u201334.","DOI":"10.1126\/science.279.5352.827"},{"key":"key\n\t\t\t\t20171011191107_B21","doi-asserted-by":"crossref","unstructured":"Hill AF, Collinge J. Subclinical prion infection. Trends Microbiol2003; 11: 578\u201384.","DOI":"10.1016\/j.tim.2003.10.007"},{"key":"key\n\t\t\t\t20171011191107_B22","doi-asserted-by":"crossref","unstructured":"Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, et al. The same prion strain causes vCJD and BSE. Nature1997; 389: 448\u201350, 526.","DOI":"10.1038\/38925"},{"key":"key\n\t\t\t\t20171011191107_B23","doi-asserted-by":"crossref","unstructured":"Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DJ, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet1999; 353: 183\u20139.","DOI":"10.1016\/S0140-6736(98)12075-5"},{"key":"key\n\t\t\t\t20171011191107_B24","doi-asserted-by":"crossref","unstructured":"Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain2003; 126: 1333\u201346.","DOI":"10.1093\/brain\/awg125"},{"key":"key\n\t\t\t\t20171011191107_B25","doi-asserted-by":"crossref","unstructured":"Hosszu LL, Jackson GS, Trevitt CR, Jones S, Batchelor M, Bhelt D, et al. The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J Biol Chem2004; 279: 28515\u201321.","DOI":"10.1074\/jbc.M313762200"},{"key":"key\n\t\t\t\t20171011191107_B26","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Huete A, Lievens PMJ, Vidal R, Piccardo P, Ghetti B, Tagliavini F, et al. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol1998; 153: 1561\u201372.","DOI":"10.1016\/S0002-9440(10)65744-6"},{"key":"key\n\t\t\t\t20171011191107_B27","doi-asserted-by":"crossref","unstructured":"Joiner S, Linehan J, Brandner S, Wadsworth JD, Collinge J. Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry2002; 73: 597\u20138.","DOI":"10.1136\/jnnp.73.5.597"},{"key":"key\n\t\t\t\t20171011191107_B28","doi-asserted-by":"crossref","unstructured":"Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol1987; 61: 3688\u201393.","DOI":"10.1128\/JVI.61.12.3688-3693.1987"},{"key":"key\n\t\t\t\t20171011191107_B29","doi-asserted-by":"crossref","unstructured":"Khalili-Shirazi A, Summers L, Linehan J, Mallinson G, Anstee D, Hawke S, et al. PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol2005; 86: 2635\u201344.","DOI":"10.1099\/vir.0.80375-0"},{"key":"key\n\t\t\t\t20171011191107_B30","doi-asserted-by":"crossref","unstructured":"Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol2002; 249: 1567\u201382.","DOI":"10.1007\/s00415-002-0896-9"},{"key":"key\n\t\t\t\t20171011191107_B31","doi-asserted-by":"crossref","unstructured":"Lawson VA, Collins SJ, Masters CL, Hill AF. Prion protein glycosylation. J Neurochem2005; 93: 793\u2013801.","DOI":"10.1111\/j.1471-4159.2005.03104.x"},{"key":"key\n\t\t\t\t20171011191107_B32","doi-asserted-by":"crossref","unstructured":"Lee HS, Brown P, Cerven\u00e1kov\u00e1 L, Garruto RM, Alpers MP, Gajdusek DC, et al. Increased susceptibility to kuru of carriers of the PRNP 129 methionine\/methionine genotype. J Infect Dis2001; 183: 192\u20136.","DOI":"10.1086\/317935"},{"key":"key\n\t\t\t\t20171011191107_B33","doi-asserted-by":"crossref","unstructured":"Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology2005; 65: 113\u20138.","DOI":"10.1212\/01.wnl.0000167188.65787.a0"},{"key":"key\n\t\t\t\t20171011191107_B34","doi-asserted-by":"crossref","unstructured":"Lloyd SE, Onwuazor ON, Beck JA, Mallinson G, Farrall M, Targonski P, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA2001; 98: 6279\u201383.","DOI":"10.1073\/pnas.101130398"},{"key":"key\n\t\t\t\t20171011191107_B35","doi-asserted-by":"crossref","unstructured":"Lloyd SE, Linehan JM, Desbruslais M, Joiner S, Buckell J, Brandner S, et al. Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol2004; 85: 2471\u20138.","DOI":"10.1099\/vir.0.79889-0"},{"key":"key\n\t\t\t\t20171011191107_B36","doi-asserted-by":"crossref","unstructured":"Mallucci GR, Campbell TA, Dickinson A, Beck J, Holt M, Plant G, et al. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain1999; 122: 1823\u201337.","DOI":"10.1093\/brain\/122.10.1823"},{"key":"key\n\t\t\t\t20171011191107_B37","doi-asserted-by":"crossref","unstructured":"Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science2003; 300: 640\u20133.","DOI":"10.1126\/science.1083320"},{"key":"key\n\t\t\t\t20171011191107_B38","doi-asserted-by":"crossref","unstructured":"Notari S, Capellari S, Giese A, Westner I, Baruzzi A, Ghetti B, et al. Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem2004; 279: 16797\u2013804.","DOI":"10.1074\/jbc.M313220200"},{"key":"key\n\t\t\t\t20171011191107_B39","doi-asserted-by":"crossref","unstructured":"Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature1991; 352: 340\u20132.","DOI":"10.1038\/352340a0"},{"key":"key\n\t\t\t\t20171011191107_B40","doi-asserted-by":"crossref","unstructured":"Palmer MS, van Leeven RH, Mahal SP, Campbell TA, Humphreys C, Collinge J. Sequence variation in intron of prion protein gene, crucial for complete diagnostic strategies. Hum Mutat1996; 7: 280\u20131.","DOI":"10.1002\/(SICI)1098-1004(1996)7:3<280::AID-HUMU17>3.0.CO;2-Z"},{"key":"key\n\t\t\t\t20171011191107_B41","doi-asserted-by":"crossref","unstructured":"Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol1995; 38: 21\u20139.","DOI":"10.1002\/ana.410380107"},{"key":"key\n\t\t\t\t20171011191107_B42","doi-asserted-by":"crossref","unstructured":"Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol1996; 39: 767\u201378.","DOI":"10.1002\/ana.410390613"},{"key":"key\n\t\t\t\t20171011191107_B43","doi-asserted-by":"crossref","unstructured":"Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, et al. Typing prion isoforms. Nature1997; 386: 232\u20134.","DOI":"10.1038\/386232a0"},{"key":"key\n\t\t\t\t20171011191107_B44","doi-asserted-by":"crossref","unstructured":"Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H, et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Str\u00e4ussler-Scheinker disease. Proc Natl Acad Sci USA1998; 95: 8322\u20137.","DOI":"10.1073\/pnas.95.14.8322"},{"key":"key\n\t\t\t\t20171011191107_B45","doi-asserted-by":"crossref","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol1999; 46: 224\u201333.","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20171011191107_B46","doi-asserted-by":"crossref","unstructured":"Parchi P, Zou WQ, Wang W, Brown P, Capellari S, Ghetti B, et al. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA2000; 97: 10168\u201372.","DOI":"10.1073\/pnas.97.18.10168"},{"key":"key\n\t\t\t\t20171011191107_B47","doi-asserted-by":"crossref","unstructured":"Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem1996; 271: 12661\u20138.","DOI":"10.1074\/jbc.271.21.12661"},{"key":"key\n\t\t\t\t20171011191107_B48","doi-asserted-by":"crossref","unstructured":"Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D, et al. Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol1998; 57: 979\u201388.","DOI":"10.1097\/00005072-199810000-00010"},{"key":"key\n\t\t\t\t20171011191107_B49","doi-asserted-by":"crossref","unstructured":"Piccardo P, Liepnieks JJ, William A, Dlouhy SR, Farlow MR, Young K, et al. Prion proteins with different conformations accumulate in Gerstmann-Straussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol2001; 158: 2201\u20137.","DOI":"10.1016\/S0002-9440(10)64692-5"},{"key":"key\n\t\t\t\t20171011191107_B50","doi-asserted-by":"crossref","unstructured":"Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol2005; 4: 805\u201314.","DOI":"10.1016\/S1474-4422(05)70225-8"},{"key":"key\n\t\t\t\t20171011191107_B51","doi-asserted-by":"crossref","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci USA1998; 95: 13363\u201383.","DOI":"10.1073\/pnas.95.23.13363"},{"key":"key\n\t\t\t\t20171011191107_B52","doi-asserted-by":"crossref","unstructured":"Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrPSc in the same brain. Neurology1999; 53: 2173\u20136.","DOI":"10.1212\/WNL.53.9.2173"},{"key":"key\n\t\t\t\t20171011191107_B53","doi-asserted-by":"crossref","unstructured":"Silvestrini MC, Cardone F, Maras B, Pucci P, Barra D, Brunori M, et al. Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients. Nat Med1997; 3: 521\u20135.","DOI":"10.1038\/nm0597-521"},{"key":"key\n\t\t\t\t20171011191107_B54","doi-asserted-by":"crossref","unstructured":"Tagliavini F, Lievens PMJ, Tranchant C, Warter JM, Mohr M, Giaccone G, et al. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Straussler-Scheinker disease A117V. J Biol Chem2001; 276: 6009\u201315.","DOI":"10.1074\/jbc.M007062200"},{"key":"key\n\t\t\t\t20171011191107_B55","doi-asserted-by":"crossref","unstructured":"Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol1999; 1: 55\u20139.","DOI":"10.1038\/9030"},{"key":"key\n\t\t\t\t20171011191107_B56","doi-asserted-by":"crossref","unstructured":"Wadsworth JDF, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob using a highly sensitive immuno-blotting assay. Lancet2001; 358: 171\u201380.","DOI":"10.1016\/S0140-6736(01)05403-4"},{"key":"key\n\t\t\t\t20171011191107_B57","doi-asserted-by":"crossref","unstructured":"Wadsworth JDF, Hill AF, Beck JA, Collinge J. Molecular and clinical classification of human prion disease. Br Med Bull2003; 66: 241\u201354.","DOI":"10.1093\/bmb\/66.1.241"},{"key":"key\n\t\t\t\t20171011191107_B58","doi-asserted-by":"crossref","unstructured":"Wadsworth JDF, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science2004; 306: 1793\u20136.","DOI":"10.1126\/science.1103932"},{"key":"key\n\t\t\t\t20171011191107_B59","doi-asserted-by":"crossref","unstructured":"Zanusso G, Farinazzo A, Fiorini M, Gelati M, Castagna A, Righetti PG, et al. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease. J Biol Chem2001; 276: 40377\u201380.","DOI":"10.1074\/jbc.C100458200"},{"key":"key\n\t\t\t\t20171011191107_B60","doi-asserted-by":"crossref","unstructured":"Zanusso G, Farinazzo A, Prelli F, Fiorini M, Gelati M, Ferrari S, et al. Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J Biol Chem2004; 279: 38936\u201342.","DOI":"10.1074\/jbc.M405468200"},{"key":"key\n\t\t\t\t20171011191107_B61","doi-asserted-by":"crossref","unstructured":"Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem2003; 278: 40429\u201336.","DOI":"10.1074\/jbc.M308550200"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/129\/3\/676\/1103050\/awl013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T03:42:53Z","timestamp":1586662973000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/129\/3\/676\/390926\/Distinct-glycoform-ratios-of-protease-resistant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,16]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,1,16]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awl013","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,3]]},"published":{"date-parts":[[2006,1,16]]}}}